Pro-Life Leaders Urge FDA Nominee to Restore Mifepristone Restrictions

Fifty pro-life leaders urged FDA commissioner nominee Heidi Overton to restore earlier restrictions on mifepristone while the agency completes its review. Their statement seeks changes including a return to in-person dispensing requirements. At her confirmation hearing, Overton said the drug had met FDA safety and efficacy standards and declined to prejudge the review.